BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20638902)

  • 1. Development of aptamer therapeutics.
    Bunka DH; Platonova O; Stockley PG
    Curr Opin Pharmacol; 2010 Oct; 10(5):557-62. PubMed ID: 20638902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic applications of aptamers.
    Kaur G; Roy I
    Expert Opin Investig Drugs; 2008 Jan; 17(1):43-60. PubMed ID: 18095918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleic acid aptamers: research tools in disease diagnostics and therapeutics.
    Santosh B; Yadava PK
    Biomed Res Int; 2014; 2014():540451. PubMed ID: 25050359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
    Kim M; Kim DM; Kim KS; Jung W; Kim DE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamers used for biosensors and targeted therapy.
    Ning Y; Hu J; Lu F
    Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidote control of aptamer therapeutics: the road to a safer class of drug agents.
    Bompiani KM; Woodruff RS; Becker RC; Nimjee SM; Sullenger BA
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1924-34. PubMed ID: 22352726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific aptamer-mediated targeted drug delivery.
    Zhou J; Rossi JJ
    Oligonucleotides; 2011 Feb; 21(1):1-10. PubMed ID: 21182455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers as Therapeutics.
    Nimjee SM; White RR; Becker RC; Sullenger BA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():61-79. PubMed ID: 28061688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.
    Ng EW; Shima DT; Calias P; Cunningham ET; Guyer DR; Adamis AP
    Nat Rev Drug Discov; 2006 Feb; 5(2):123-32. PubMed ID: 16518379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR; Roy K; Kanwar RK
    Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current progress on aptamer-targeted oligonucleotide therapeutics.
    Dassie JP; Giangrande PH
    Ther Deliv; 2013 Dec; 4(12):1527-46. PubMed ID: 24304250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers: Cutting edge of cancer therapies.
    Shigdar S; Schrand B; Giangrande PH; de Franciscis V
    Mol Ther; 2021 Aug; 29(8):2396-2411. PubMed ID: 34146729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering polymeric aptamers for selective cytotoxicity.
    Yang L; Meng L; Zhang X; Chen Y; Zhu G; Liu H; Xiong X; Sefah K; Tan W
    J Am Chem Soc; 2011 Aug; 133(34):13380-6. PubMed ID: 21702469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
    Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application.
    Adachi T; Nakamura Y
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and perspectives in cell-specific aptamers.
    Sun W; Du L; Li M
    Curr Pharm Des; 2011; 17(1):80-91. PubMed ID: 21342116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamers: multifunctional molecules for biomedical research.
    Banerjee J; Nilsen-Hamilton M
    J Mol Med (Berl); 2013 Dec; 91(12):1333-42. PubMed ID: 24045702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.